CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 146 enrolled
Drug / intervention
Glucose oxidase+5%glucose +1 moredevice
Likely dose
Glucose oxidase+5%glucosefrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01883453
NCT01883453Phase 2Completed
CompareCT.gov

A Double Blinded Clinical Study Aiming to Shorten an Episode of Common Cold When the Treatment is Started at the Onset of an Episode of Common Cold

Umeå University·interventional·Posted Jun 21, 2013·Updated Nov 9, 2015

In Brief

A Phase 2 clinical trial evaluating Glucose oxidase+5%glucose and Saline+5%glucose for Common Cold. Completed, enrolled 146 participants across 2 sites.

Detailed Summary

Healthy persons are invited to participate in the study and are given a home protocol (WURSS21), nasal spray and a sample pin. The included persons are told to make a nasopharyngeal sampling from the nose when they are sure that they have caught a common cold. After the sampling they start to spray and also fill in the records daily. The aim of the study is to investigate whether a nasal spray with glucose oxidase could shorten an episode of common cold.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCommon Cold
CountriesSweden
Collaborators--

Timeline

Phase 2CompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedJun 21, 2013
Enrollment StartJan 1, 2013
Primary CompletionMay 1, 2013
Study CompletionSep 1, 2013
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 13.0 years ago

Interventions

Glucose oxidase+5%glucosedevice

A hydrogen peroxide producing enzyme

Saline+5%glucosedevice

Isotonic saline + 5% glucose in a bag-on-valve nasal spray device